IRIS
CACCIOLA, Irene
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.728
EU - Europa 1.818
AS - Asia 1.483
SA - Sud America 576
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 6.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.681
SG - Singapore 637
BR - Brasile 510
IE - Irlanda 492
SE - Svezia 421
CN - Cina 418
IT - Italia 334
HK - Hong Kong 196
DE - Germania 143
VN - Vietnam 75
FI - Finlandia 74
UA - Ucraina 66
RU - Federazione Russa 58
GB - Regno Unito 56
PL - Polonia 49
IN - India 46
FR - Francia 34
AR - Argentina 30
BE - Belgio 27
CA - Canada 23
ZA - Sudafrica 18
TR - Turchia 16
AT - Austria 14
MX - Messico 14
JP - Giappone 13
BD - Bangladesh 12
ID - Indonesia 12
NL - Olanda 12
UZ - Uzbekistan 10
CL - Cile 9
MA - Marocco 9
EC - Ecuador 8
ES - Italia 8
IQ - Iraq 7
AZ - Azerbaigian 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
CZ - Repubblica Ceca 5
CI - Costa d'Avorio 4
EG - Egitto 4
GR - Grecia 4
JO - Giordania 4
KE - Kenya 4
LT - Lituania 4
PK - Pakistan 4
DZ - Algeria 3
IL - Israele 3
IR - Iran 3
LB - Libano 3
MD - Moldavia 3
NO - Norvegia 3
PA - Panama 3
SN - Senegal 3
AL - Albania 2
AO - Angola 2
EU - Europa 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PE - Perù 2
TG - Togo 2
UY - Uruguay 2
VE - Venezuela 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KR - Corea 1
LC - Santa Lucia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.664
Salva come PNG Salva come JPEG
Città #
Dublin 492
Dallas 489
Ashburn 383
Singapore 340
Chandler 294
Nyköping 279
Hong Kong 196
Beijing 169
Messina 155
Jacksonville 146
Los Angeles 90
Ann Arbor 75
Princeton 67
Medford 62
The Dalles 60
Munich 56
Des Moines 50
Dearborn 44
São Paulo 43
New York 41
Cambridge 40
Warsaw 38
Boardman 29
Ho Chi Minh City 27
Buffalo 25
Brussels 24
Jinan 24
Redondo Beach 21
Hanoi 20
Rosolini 19
Turku 19
Woodbridge 19
Moscow 18
Rio de Janeiro 18
Helsinki 17
Nuremberg 17
Seattle 17
Belo Horizonte 16
Hyderabad 15
Nanjing 15
Rome 15
Tianjin 15
Houston 13
Tokyo 13
San Francisco 12
San Mateo 12
Wilmington 12
Brooklyn 11
Catania 11
Hebei 11
Jakarta 11
Frankfurt am Main 10
Pune 10
Shenyang 10
Amsterdam 9
Avola 9
Orem 9
Porto Alegre 9
Vienna 9
Ankara 8
Atlanta 8
Chennai 8
Chicago 8
Denver 8
Haikou 8
Boston 7
Bremen 7
Guangzhou 7
Johannesburg 7
Pachino 7
Phoenix 7
Shanghai 7
Stockholm 7
Tashkent 7
Baku 6
Brasília 6
Düsseldorf 6
Hangzhou 6
London 6
Montreal 6
Querétaro 6
Salvador 6
Santa Clara 6
Changsha 5
Fuzhou 5
Hefei 5
Mumbai 5
Palermo 5
Serra 5
São José dos Campos 5
Taizhou 5
Viamão 5
Zhengzhou 5
Abidjan 4
Athens 4
Baghdad 4
Brno 4
Cape Town 4
Columbus 4
Council Bluffs 4
Totale 4.423
Salva come PNG Salva come JPEG
Nome #
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 191
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 187
Atrial fibrillation in patients with cirrhosis 174
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 163
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 147
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 136
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 131
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 128
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 127
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 123
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 121
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 119
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 118
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 118
Outcome of cutaneous psoriasis in hepatitis C virus-infected patients treated with Direct-Acting Antiviral therapy 116
Erectile dysfunction in compensated liver cirrhosis 115
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 114
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 109
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 108
Prevalence of hepatitis B and C viral infections in hospitalized patients with increased liver enzyme levels and with no known history of hepatic disease 108
Oscillazione dei livelli di viremia in soggetti portatori cromici asintomatici di infezione da virus B. Dati preliminari 106
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 104
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 104
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 102
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 102
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 100
New-Onset Atrial Fibrillation and Early Mortality Rate in COVID-19 Patients: Association with IL-6 Serum Levels and Respiratory Distress 100
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance 99
Effectiveness of add-on Pegylated interferon alfa-2a therapy in a Lamivudine-treated patient with chronic hepatitis B 99
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 99
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 98
Molecular analyses of TT virus in paired and tissue samples from 150 patients with either hepatic or non-hepatic disease 94
Strain endocardico longitudinale tra pazienti cirrotici di classe A e B al punteggio di Child-Pugh 94
Impact of Occult Hepatitis B Virus Infection on the Outcome of Chronic Hepatitis C. 94
Oscillazione dei livelli di viremia in soggetti portatori cronici asintomatici di infezione da virus b. Dati preliminari 93
Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study 91
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 90
Fever and rhomboid target lesion in decompensated cirrhosis 90
Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. 88
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. 86
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 86
Mucocutaneous toxicity during simeprevir treatment for hepatitis C. A single institution, retrospective case series 85
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 84
Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. 82
Assessing Genomic Mutations in SARS-CoV-2: Potential Resistance to Antiviral Drugs in Viral Populations from Untreated COVID-19 Patients 81
Hepatitis B virus PreS/S gene variants: Pathobiology and clinical implications. 81
Dermatiti iatrogene in corso di trattamento dell’epatopatia HCV-correlata con simeprevir 81
Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. 79
Long-term response to interferon alpha is unrelated to "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection 77
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 76
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience 76
Health economics aspects of kidney transplantation in Sicily: a benchmark analysis on activity and estimated savings 75
PREVALENCE OF BACTERIAL RESISTANCE IN CIRRHOTIC PATIENTS WITH BACTERIAL INFECTION: A PRELIMINARY REPORT 75
Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease 74
Infezione occulta da virus dell’epatite B in pazienti con epatite cronica virus con correlata valutazione istologica 72
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease 71
Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. 70
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis. 70
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 69
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 68
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 67
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes 66
The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study 63
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis 61
ACUTE KIDNEY INJURY IN CIRRHOTIC PATIENTS UNDERGOING CONTRAST-ENHANCED COMPUTED TOMOGRAPHY 58
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 57
Effects of Proton Pump Inhibitors in Cirrhotic Patients: What Do We Really Know? 57
Occult hepatitis B virus infection 54
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 54
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort 48
Long-term virological and clinical evaluation of chronic hepatitis B patients under nucleos(t)ide analogues therapy 41
RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study 29
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 26
Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies 25
null 22
null 20
MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression 7
Totale 6.873
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.589
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021221 0 0 0 0 0 30 21 48 39 45 22 16
2021/2022481 13 53 14 14 36 4 52 11 7 66 65 146
2022/20231.347 81 162 73 89 86 127 32 77 556 7 37 20
2023/2024340 27 61 20 36 31 44 7 10 3 44 18 39
2024/20251.668 30 27 44 118 77 71 83 326 378 89 167 258
2025/20261.986 278 467 420 357 433 31 0 0 0 0 0 0
Totale 6.873